FluiDx-AD
Developing a test trio for enhanced diagnosis & management of Alzheimer's.
X
X
Visit our website
Visit our website
FluiDx-AD is a collaborative Horizon Europe-funded project aimed at improving Alzheimer’s disease diagnosis and management.
FluiDx-AD introduction
Vimeo
FluiDx-AD introduction
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily re flect those of the European Union. Neither…
Newsletter sign-up
Newsletter sign-up
FluiDx-AD Email Forms
LinkedIn
LinkedIn
FluiDx-AD | 91 followers on LinkedIn. Our mission is to develop a novel test trio for enhanced diagnosis and management of Alzheimer's disease. | FluiDx-AD seeks to develop a trio of complementary tests: SalivaDx-AD: An easy-to-use, at-home saliva test for population-wide detection of individuals at risk of developing AD in its prodromal stages. PlasmaDx-AD: A minimally invasive and cost-effective blood test for high-precision confirmatory diagnosis for individuals with suspected AD. BloodCellDx-AD: A minimally invasive, whole blood ex vivo test system to evaluate the risk of amyloid-related imaging abnormalities (ARIA), to support patient eligibility assessments and ARIA monitoring for anti-amyloid therapies
Bluesky
Bluesky
Publications repository
Publications repository
View on mobile
